Enrolling

The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and…

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…

The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and…

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will…

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The…

The purpose of this study is to evaluate the efficacy of the medication JTT-861 administered for 12 weeks in subjects with heart failure…

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type…